What’s with Bris­tol My­ers’ R&D job cuts in New Jer­sey? They’re not say­ing much

It’s not un­usu­al these days to hear chat­ter about R&D lay­offs, with biotechs of all stripes cut­ting back and carv­ing out longer run­ways through cost re­duc­tions. But buzz about a burst of Bris­tol My­ers Squibb re­sumes hit­ting the mar­ket out of New Jer­sey drew some spe­cial at­ten­tion.

I queried a spokesper­son for the com­pa­ny and re­ceived this re­sponse late Fri­day:

We re­cent­ly formed a new Im­munol­o­gy and Car­dio­vas­cu­lar The­mat­ic Re­search Cen­ter to bet­ter sup­port our R&D pro­grams. As we re­fo­cus hir­ing ef­forts in con­nec­tion with that ef­fort, a lim­it­ed num­ber of our R&D col­leagues in New Jer­sey have been im­pact­ed. As al­ways, BMS is work­ing to sup­port all im­pact­ed em­ploy­ees.

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.

UPGRADE